Cargando…

TROY Modulates Cancer Stem-Like Cell Properties and Gefitinib Resistance Through EMT Signaling in Non–Small Cell Lung Cancer

Targeted therapy has made breakthrough progress in the treatment of advanced non–small cell lung cancer (NSCLC) in the last 20 years. Despite that, acquired resistance of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is an urgent clinical problem. Our study established an acq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Linying, Yu, Yuman, Xu, Liming, Wang, Xiaoling, Zhou, Jianying, Wang, Yuehong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136171/ https://www.ncbi.nlm.nih.gov/pubmed/35646083 http://dx.doi.org/10.3389/fgene.2022.881875

Ejemplares similares

SETD4 Confers Cancer Stem Cell Chemoresistance in Nonsmall Cell Lung Cancer Patients via the Epigenetic Regulation of Cellular Quiescence
por: Wang, Yuehong, et al.
Publicado: (2023)

Virchow and Troy
por: Paksoy, Nadir
Publicado: (2023)

Troy : lord of the silver bow /
por: Gemmell, David
Publicado: (2005)

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with bevacizumab for advanced non-squamous non-small-cell lung cancer patients with gradual progression on EGFR-TKI treatment: A cohort study
por: Yu, Yuman, et al.
Publicado: (2021)

Acoustics for engineers: Troy lectures
por: Blauert, Jens, et al.
Publicado: (2009)

Facts from the Small-Pox Hospital at Troy, New York
por: Schuyler, Clarkson C.
Publicado: (1881)

The walls of Windy Troy; a biography of Heinrich Schliemann.
por: Braymer, Marjorie
Publicado: (1960)

Inhibiting of TACC3 Promotes Cell Proliferation, Cell Invasion and the EMT Pathway in Breast Cancer
por: Huo, Qin, et al.
Publicado: (2021)

Cellular Senescence: A Troy Horse in Pulmonary Fibrosis
por: Wan, Ruyan, et al.
Publicado: (2023)

TROY interacts with RKIP to promote glioma development
por: Liu, Xiujie, et al.
Publicado: (2018)

Meeting of the Members of the Medical Profession of the City of Troy
Publicado: (1854)

Gefitinib in Non Small Cell Lung Cancer
por: Costanzo, Raffaele, et al.
Publicado: (2011)

PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy
por: Fidler, M J, et al.
Publicado: (2011)

Delta-catenin attenuates medulloblastoma cell invasion by targeting EMT pathway
por: Hu, Yuanjun, et al.
Publicado: (2022)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer
por: Dai, Weiyu, et al.
Publicado: (2021)

Propentofylline Targets TROY, a Novel Microglial Signaling Pathway
por: Jacobs, Valerie L., et al.
Publicado: (2012)

A molecular portrait of maternal sepsis from Byzantine Troy
por: Devault, Alison M, et al.
Publicado: (2017)

Death of Dr. Thomas W. Blatchford, of Troy, N. Y.
Publicado: (1866)

Death of Dr. Thomas C. Brinsmade of Troy, N. Y.
Publicado: (1868)

Troy/Tnfrsf19 marks epidermal cells that govern interfollicular epidermal renewal and cornification
por: Kretzschmar, Kai, et al.
Publicado: (2021)

Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer
por: Shen, Hua, et al.
Publicado: (2014)

Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
por: Araki, Takuya, et al.
Publicado: (2012)

Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis
por: Yi, Min, et al.
Publicado: (2023)

The nutritional phenome of EMT-induced cancer stem-like cells
por: Cuyàs, Elisabet, et al.
Publicado: (2014)

Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer
por: Cai, Luya, et al.
Publicado: (2020)

Phase I study of irinotecan and gefitinib in patients with gefitinib treatment failure for non-small cell lung cancer
por: Horiike, A, et al.
Publicado: (2011)

PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival
por: Ding, Zonghui, et al.
Publicado: (2018)

TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance
por: Ding, Zonghui, et al.
Publicado: (2020)

CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression
por: Gao, Zhao-wei, et al.
Publicado: (2021)

Correction: Propentofylline Targets TROY, a Novel Microglial Signaling Pathway
por: Jacobs, Valerie L., et al.
Publicado: (2013)

GATA3 Truncation Mutants Alter EMT Related Gene Expression via Partial Motif Recognition in Luminal Breast Cancer Cells
por: Saotome, Mika, et al.
Publicado: (2022)

Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
por: Tang, Mei-Chuan, et al.
Publicado: (2015)

ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells
por: Qi, Mengfan, et al.
Publicado: (2018)

Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
por: Sudo, Makoto, et al.
Publicado: (2013)

Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
por: Araki, Takuya, et al.
Publicado: (2013)

The Role of Gefitinib in Patients with Non-small-cell Lung Cancer in India
por: Mehta, Asmita Anilkumar, et al.
Publicado: (2013)

Choroidal Metastasis of Non-Small Cell Lung Cancer That Responded to Gefitinib
por: Shimomura, Iwao, et al.
Publicado: (2013)

Optimizing response to gefitinib in the treatment of non-small-cell lung cancer
por: Carotenuto, Pietro, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1gq55il9sq2e108df588f38jpp